← United States · Coverage record
US · SEC FORM 4
Nuvation Bio Inc.
NUVB · NYSE · CIK 0001811063 · Healthcare · Biotechnology
INSIDER SIGNAL
1 qualifying P purchase group
in the current 180-day scoring window
12 Form 4 transaction lines observed in the same window
4 sales · 7 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-06-09 · Mashal Robert.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 58,862,812
- Previous report
- 58,173,586
- Avg daily volume
- 4,240,489
- Days to cover
- 13.9
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-09 | Mashal Robert | Purchase (P) | Class A Common Stock | 25,000 | USD 4.73 | USD 118,250 | SEC filing ↗ |
| 2025-06-18 | Markel Stacy | Purchase (P) | Class A Common Stock | 10,000 | USD 1.71 | USD 17,100 | SEC filing ↗ |
| 2025-06-17 | Sauvage Philippe | Purchase (P) | Class A Common Stock | 4,000 | USD 1.79 | USD 7,160 | SEC filing ↗ |
| 2025-06-16 | Wentworth Kerry | Purchase (P) | Class A Common Stock | 50,000 | USD 1.79 | USD 89,740 | SEC filing ↗ |
| 2025-06-16 | Sjogren Colleen | Purchase (P) | Class A Common Stock | 50,000 | USD 1.81 | USD 90,500 | SEC filing ↗ |
| 2025-06-16 | Sauvage Philippe | Purchase (P) | Class A Common Stock | 3,300 | USD 1.84 | USD 6,072 | SEC filing ↗ |
| 2025-06-16 | Hung David | Purchase (P) | Class A Common Stock | 500,000 | USD 1.79 | USD 895,000 | SEC filing ↗ |
| 2025-04-07 | Hung David | Purchase (P) | Class A Common Stock | 300,000 | USD 1.63 | USD 489,000 | SEC filing ↗ |
| 2025-04-04 | Hung David | Purchase (P) | Class A Common Stock | 200,000 | USD 1.66 | USD 332,000 | SEC filing ↗ |
| 2025-04-01 | Mashal Robert | Purchase (P) | Class A Common Stock | 100,000 | USD 1.67 | USD 167,000 | SEC filing ↗ |
| 2024-10-08 | Mashal Robert | Purchase (P) | Class A Common Stock | 100,000 | USD 2.20 | USD 220,000 | SEC filing ↗ |
| 2024-06-25 | Cui Xiangmin | Purchase (P) | Class A Common Stock | 277,895 | USD 2.97 | USD 825,348 | SEC filing ↗ |
| 2024-06-24 | Cui Xiangmin | Purchase (P) | Class A Common Stock | 336,874 | USD 2.98 | USD 1,003,885 | SEC filing ↗ |
| 2024-06-21 | Cui Xiangmin | Purchase (P) | Class A Common Stock | 75,411 | USD 3.00 | USD 226,233 | SEC filing ↗ |
| 2024-06-20 | Cui Xiangmin | Purchase (P) | Class A Common Stock | 87,715 | USD 2.99 | USD 262,268 | SEC filing ↗ |
Form 4 evidence
40 transaction lines in the latest 365-day window; 126 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Hattersley Gary | Sale (S) | Class A Common Stock | 100,000 | USD 7.09 | USD 709,000 | SEC filing ↗ |
| 2026-08-19 | Hattersley Gary | Option exercise / conversion (M) | Class A Common Stock | 100,000 | USD 1.87 | USD 187,000 | SEC filing ↗ |
| 2026-07-15 | Sauvage Philippe | Option exercise / conversion (M) | Class A Common Stock | 40,000 | USD 2.17 | USD 86,800 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Hattersley Gary | Sale (S) | Class A Common Stock | 100,000 | USD 7.09 | USD 709,000 | SEC filing ↗ |
| 2026-08-19 | Hattersley Gary | Option exercise / conversion (M) | Class A Common Stock | 100,000 | USD 1.87 | USD 187,000 | SEC filing ↗ |
| 2026-07-15 | Sauvage Philippe | Option exercise / conversion (M) | Class A Common Stock | 40,000 | USD 2.17 | USD 86,800 | SEC filing ↗ |
| 2026-06-23 | Wentworth Kerry | Sale (S) | Class A Common Stock | 63,000 | USD 6.02 | USD 379,260 | SEC filing ↗ |
| 2026-06-23 | Wentworth Kerry | Option exercise / conversion (M) | Class A Common Stock | 63,000 | USD 2.93 | USD 184,590 | SEC filing ↗ |
| 2026-06-23 | Sauvage Philippe | Sale (S) | Class A Common Stock | 47,668 | USD 6.01 | USD 286,485 | SEC filing ↗ |
| 2026-06-23 | Sauvage Philippe | Option exercise / conversion (M) | Class A Common Stock | 47,668 | USD 2.17 | USD 103,440 | SEC filing ↗ |
| 2026-06-23 | Markel Stacy | Sale (S) | Class A Common Stock | 125,000 | USD 6.03 | USD 753,750 | SEC filing ↗ |
| 2026-06-23 | Markel Stacy | Option exercise / conversion (M) | Class A Common Stock | 125,000 | USD 1.83 | USD 229,249 | SEC filing ↗ |
| 2026-06-09 | Mashal Robert | Purchase (P) | Class A Common Stock | 25,000 | USD 4.73 | USD 118,250 | SEC filing ↗ |
| 2026-04-17 | Wentworth Kerry | Sale (S) | Class A Common Stock | 36,750 | USD 5.01 | USD 184,118 | SEC filing ↗ |
| 2026-04-17 | Wentworth Kerry | Option exercise / conversion (M) | Class A Common Stock | 36,750 | USD 2.93 | USD 107,678 | SEC filing ↗ |
| 2026-04-17 | Liu Dongfang | Sale (S) | Class A Common Stock | 50,000 | USD 5.02 | USD 251,000 | SEC filing ↗ |
| 2026-04-17 | Liu Dongfang | Option exercise / conversion (M) | Class A Common Stock | 50,000 | USD 1.94 | USD 97,000 | SEC filing ↗ |
| 2026-04-06 | Wentworth Kerry | Sale (S) | Class A Common Stock | 200,000 | USD 4.52 | USD 904,000 | SEC filing ↗ |
| 2026-04-06 | Wentworth Kerry | Option exercise / conversion (M) | Class A Common Stock | 200,000 | USD 1.91 | USD 381,000 | SEC filing ↗ |
| 2026-02-27 | Makunje Moses | Award / grant (A) | Class A Common Stock | 50,761 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-01 | Liu Dongfang | Sale (S) | Class A Common Stock | 150,000 | USD 7.82 | USD 1,173,000 | SEC filing ↗ |
| 2025-12-01 | Liu Dongfang | Option exercise / conversion (M) | Class A Common Stock | 150,000 | USD 2.93 | USD 439,500 | SEC filing ↗ |
| 2025-11-26 | Liu Dongfang | Sale (S) | Class A Common Stock | 10,000 | USD 8.00 | USD 80,000 | SEC filing ↗ |
| 2025-11-26 | Liu Dongfang | Option exercise / conversion (M) | Class A Common Stock | 10,000 | USD 3.61 | USD 36,100 | SEC filing ↗ |
| 2025-11-25 | Liu Dongfang | Sale (S) | Class A Common Stock | 10,000 | USD 7.50 | USD 75,000 | SEC filing ↗ |
| 2025-11-25 | Liu Dongfang | Option exercise / conversion (M) | Class A Common Stock | 10,000 | USD 3.61 | USD 36,100 | SEC filing ↗ |
| 2025-11-20 | Liu Dongfang | Sale (S) | Class A Common Stock | 20,000 | USD 7.00 | USD 140,000 | SEC filing ↗ |
| 2025-11-20 | Liu Dongfang | Option exercise / conversion (M) | Class A Common Stock | 20,000 | USD 1.87 | USD 37,400 | SEC filing ↗ |
| 2025-11-20 | Hattersley Gary | Sale (S) | Class A Common Stock | 369,051 | USD 7.23 | USD 2,668,239 | SEC filing ↗ |
| 2025-11-20 | Hattersley Gary | Option exercise / conversion (M) | Class A Common Stock | 369,051 | USD 1.90 | USD 702,149 | SEC filing ↗ |
| 2025-11-19 | Hanley David C. | Sale (S) | Class A Common Stock | 200,000 | USD 7.14 | USD 1,428,000 | SEC filing ↗ |
| 2025-11-19 | Hanley David C. | Option exercise / conversion (M) | Class A Common Stock | 200,000 | USD 1.87 | USD 374,000 | SEC filing ↗ |
| 2025-11-19 | Liu Dongfang | Sale (S) | Class A Common Stock | 15,000 | USD 5.10 | USD 76,500 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | NUVB |
| CIK | 0001811063 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 126 transaction lines from 2020-02-10 to 2026-08-19 41 P purchase lines · 29 S sale lines · 56 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.